MedTrace Logo

Nippon Ultra-Rapid Insulin and Diabetic Complication Evaluation-Study (NICE-Study)

NCT00575172 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 346

Last updated 2008-01-14

No results posted yet for this study

Summary

For the purpose of comparing efficacy of intensive therapy between 1) ultrarapid-acting type insulin (insulin aspart) and 2) conventional rapid-acting type insulin (R), a Multicenter Open Label Randomized Controlled Trial was planned in Japan using the occurrence of cardiovascular events in patients with diabetes, a high risk factor, as an index.

Conditions

Sponsors & Collaborators

  • Osaka Saiseikai Nakatsu Hospital

    lead OTHER

Principal Investigators

  • Hideshi Kuzuya, M.D.,Ph.D · Higasiyama Takeda Hospital

  • Makoto Otoshi, MD.,Ph.D. · Ohtoshi Clinic

  • Haruo Nishimura, MD.,Ph.D. · Osaka Saiseikai Nakatsu Hospital

  • Koji Maeda, MD. · Maeda Clinic

  • Mitsuyo Shintani, MD.,Ph.D. · Osaka Saiseikai Nakatsu Hospital

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Completion
2007-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00575172 on ClinicalTrials.gov